{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:03:12Z","timestamp":1784804592754,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803011"],"award-info":[{"award-number":["81803011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Project of Higher Education Institutions in Henan Province","award":["24A310022"],"award-info":[{"award-number":["24A310022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02224-9","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:18:16Z","timestamp":1768918696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRPS1 confers paclitaxel resistance in TNBC through dual activation of the PDE4D\u2013cAMP\u2013AKT pathway and microtubule destabilization"],"prefix":"10.1186","volume":"28","author":[{"given":"Xin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"20","key":"2224_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"2224_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2224_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2224_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275\u201381.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2224_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2224_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol. 2023;16(1):100.","journal-title":"J Hematol Oncol"},{"issue":"3-4","key":"2224_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1101\/gad.331371.119","volume":"34","author":"LM Cornelissen","year":"2020","unstructured":"Cornelissen LM, Drenth AP, van der Burg E, et al. TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth\/differentiation and breast cancer development. Genes Dev. 2020;34(3\u20134):179\u201393.","journal-title":"Genes Dev"},{"issue":"10","key":"2224_CR8","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/annonc\/mdt190","volume":"24","author":"JQ Chen","year":"2013","unstructured":"Chen JQ, Bao Y, Lee J, et al. Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer. Ann Oncol. 2013;24(10):2534\u201342.","journal-title":"Ann Oncol"},{"key":"2224_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154022","volume":"237","author":"L Yang","year":"2022","unstructured":"Yang L, Gong X, Wang J, et al. Functional mechanisms of TRPS1 in disease progression and its potential role in personalized medicine. Pathol Res Pract. 2022;237:154022.","journal-title":"Pathol Res Pract"},{"key":"2224_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148880","volume":"932","author":"X He","year":"2025","unstructured":"He X, Huang H, Liu Y, et al. Analysis of the function, mechanism and clinical application prospect of TRPS1, a new marker for breast cancer. Gene. 2025;932:148880.","journal-title":"Gene"},{"issue":"6","key":"2224_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jasc.2022.06.007","volume":"11","author":"M Abdelwahed","year":"2022","unstructured":"Abdelwahed M, Yurtsever N, Savant D, et al. Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens. J Am Soc Cytopathol. 2022;11(6):345\u201351.","journal-title":"J Am Soc Cytopathol"},{"issue":"2","key":"2224_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tranon.2018.01.009","volume":"11","author":"J Hu","year":"2018","unstructured":"Hu J, Su P, Jiao M, et al. TRPS1 suppresses breast cancer epithelial-mesenchymal transition program as a negative regulator of SUZ12. Transl Oncol. 2018;11(2):416\u201325.","journal-title":"Transl Oncol"},{"key":"2224_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00934","volume":"10","author":"J Hu","year":"2020","unstructured":"Hu J, Zhang H, Liu L, et al. TRPS1 confers multidrug resistance of breast cancer cells by regulating BCRP expression. Front Oncol. 2020;10:934.","journal-title":"Front Oncol"},{"issue":"1","key":"2224_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12094-021-02676-9","volume":"24","author":"M Wu","year":"2022","unstructured":"Wu M, Sun X, Wang T, et al. TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells. Clin Transl Oncol. 2022;24(1):145\u201353.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"2224_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1535370214523904","volume":"239","author":"J Hu","year":"2014","unstructured":"Hu J, Su P, Jia M, et al. TRPS1 expression promotes angiogenesis and affects VEGFA expression in breast cancer. Exp Biol Med (Maywood). 2014;239(4):423\u20139.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"2224_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108814","volume":"34","author":"J Yang","year":"2021","unstructured":"Yang J, Liu X, Huang Y, et al. TRPS1 drives heterochromatic origin refiring and cancer genome evolution. Cell Rep. 2021;34(10):108814.","journal-title":"Cell Rep"},{"issue":"2","key":"2224_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011159","volume":"20","author":"TG Scott","year":"2024","unstructured":"Scott TG, Sathyan KM, Gioeli D, et al. TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells. PLoS Genet. 2024;20(2):e1011159.","journal-title":"PLoS Genet"},{"issue":"14","key":"2224_CR18","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2174\/138161209788168092","volume":"15","author":"HT Zhang","year":"2009","unstructured":"Zhang HT. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des. 2009;15(14):1688\u201398.","journal-title":"Curr Pharm Des"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2017.09.004","volume":"145","author":"V Garc\u00eda-Morales","year":"2017","unstructured":"Garc\u00eda-Morales V, Luaces-Regueira M, Campos-Toimil M. The cAMP effectors PKA and Epac activate endothelial NO synthase through PI3K\/Akt pathway in human endothelial cells. Biochem Pharmacol. 2017;145:94\u2013101.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2224_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Liu J, et al. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17(1):5.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2224_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1681\/ASN.2016010009","volume":"28","author":"Y Ju-Rong","year":"2017","unstructured":"Ju-Rong Y, Ke-Hong C, Kun H, et al. Transcription Factor Trps1 Promotes Tubular Cell Proliferation after Ischemia-Reperfusion Injury through cAMP-Specific 3\u2019,5\u2019-Cyclic Phosphodiesterase 4D and AKT. J Am Soc Nephrol. 2017;28(2):532\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"2224_CR22","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1038\/s41388-020-1258-8","volume":"39","author":"S Hsien Lai","year":"2020","unstructured":"Hsien Lai S, Zervoudakis G, Chou J, et al. Pde4 subtypes in cancer. Oncogene. 2020;39(19):3791\u2013802.","journal-title":"Oncogene"},{"issue":"5","key":"2224_CR23","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3892\/ol.2014.2422","volume":"8","author":"T Xu","year":"2014","unstructured":"Xu T, Wu S, Yuan Y, et al. Knockdown of phosphodiesterase 4D inhibits nasopharyngeal carcinoma proliferation via the epidermal growth factor receptor signaling pathway. Oncol Lett. 2014;8(5):2110\u20136.","journal-title":"Oncol Lett"},{"issue":"3","key":"2224_CR24","first-page":"3589","volume":"17","author":"DU Kim","year":"2019","unstructured":"Kim DU, Nam J, Cha MD, et al. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT\/mTOR\/Myc signaling pathway. Oncol Lett. 2019;17(3):3589\u201398.","journal-title":"Oncol Lett"},{"key":"2224_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215749","volume":"541","author":"H Ren","year":"2022","unstructured":"Ren H, Chen Y, Ao Z, et al. Pde4D binds and interacts with YAP to cooperatively promote HCC progression. Cancer Lett. 2022;541:215749.","journal-title":"Cancer Lett"},{"key":"2224_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216224","volume":"565","author":"B Feng","year":"2023","unstructured":"Feng B, Pan B, Huang J, et al. Pde4D\/cAMP\/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytes. Cancer Lett. 2023;565:216224.","journal-title":"Cancer Lett"},{"key":"2224_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1057083","volume":"13","author":"AD Bondarev","year":"2022","unstructured":"Bondarev AD, Attwood MM, Jonsson J, et al. Recent developments of phosphodiesterase inhibitors: clinical trials, emerging indications and novel molecules. Front Pharmacol. 2022;13:1057083.","journal-title":"Front Pharmacol"},{"issue":"12","key":"2224_CR28","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/jcb.30325","volume":"123","author":"P Mukherjee","year":"2022","unstructured":"Mukherjee P, Bagchi A, Banerjee A, et al. Pde4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTOR. J Cell Biochem. 2022;123(12):1980\u201396.","journal-title":"J Cell Biochem"},{"key":"2224_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810616","author":"C Lugnier","year":"2022","unstructured":"Lugnier C. The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231810616.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2224_CR30","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.1158\/0008-5472.CAN-11-0025","volume":"71","author":"AA Ahmed","year":"2011","unstructured":"Ahmed AA, Wang X, Lu Z, et al. Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. Cancer Res. 2011;71(17):5806\u201317.","journal-title":"Cancer Res"},{"issue":"24","key":"2224_CR31","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.7150\/thno.45207","volume":"10","author":"XY Liu","year":"2020","unstructured":"Liu XY, Jiang W, Ma D, et al. SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer. Theranostics. 2020;10(24):10940\u201356.","journal-title":"Theranostics"},{"issue":"3","key":"2224_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neulet.2010.07.044","volume":"482","author":"UB Chu","year":"2010","unstructured":"Chu UB, Song J, Mavlyutov TA, et al. In vitro interaction of tubulin with the photoreceptor cGMP phosphodiesterase gamma-subunit. Neurosci Lett. 2010;482(3):225\u20139.","journal-title":"Neurosci Lett"},{"key":"2224_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022608","author":"HV Goodson","year":"2018","unstructured":"Goodson HV, Jonasson EM. Microtubules and Microtubule-Associated Proteins. Cold Spring Harb Perspect Biol. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a022608.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"2224_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.CAN-22-2709","volume":"83","author":"L Liao","year":"2023","unstructured":"Liao L, Zhang YL, Deng L, et al. Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer. Cancer Res. 2023;83(3):471\u201384.","journal-title":"Cancer Res"},{"issue":"7","key":"2224_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/leu.2011.66","volume":"25","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Franklin RA, Abrams SL, et al. Roles of the Ras\/Raf\/MEK\/ERK pathway in leukemia therapy. Leukemia. 2011;25(7):1080\u201394.","journal-title":"Leukemia"},{"issue":"6335","key":"2224_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aai8764","volume":"356","author":"Z Xu","year":"2017","unstructured":"Xu Z, Schaedel L, Portran D, et al. Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. Science. 2017;356(6335):328\u201332.","journal-title":"Science"},{"issue":"1","key":"2224_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1517\/13543780903485642","volume":"19","author":"R Savai","year":"2010","unstructured":"Savai R, Pullamsetti SS, Banat GA, et al. Targeting cancer with phosphodiesterase inhibitors. Expert Opin Investig Drugs. 2010;19(1):117\u201331.","journal-title":"Expert Opin Investig Drugs"},{"key":"2224_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.semcancer.2020.02.004","volume":"68","author":"DR Perez","year":"2021","unstructured":"Perez DR, Sklar LA, Chigaev A, et al. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity. Semin Cancer Biol. 2021;68:199\u2013208.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2224_CR39","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1083\/jcb.106.4.1213","volume":"106","author":"JC Bulinski","year":"1988","unstructured":"Bulinski JC, Richards JE, Piperno G. Posttranslational modifications of alpha tubulin: detyrosination and acetylation differentiate populations of interphase microtubules in cultured cells. J Cell Biol. 1988;106(4):1213\u201320.","journal-title":"J Cell Biol"},{"issue":"3","key":"2224_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2014.10.004","volume":"25","author":"Y Song","year":"2015","unstructured":"Song Y, Brady ST. Post-translational modifications of tubulin: pathways to functional diversity of microtubules. Trends Cell Biol. 2015;25(3):125\u201336.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"2224_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00018-024-05565-w","volume":"82","author":"S Song","year":"2024","unstructured":"Song S, Ko P, Keum S, et al. Microtubule acetylation and PERK activation facilitate eribulin-induced mitochondrial calcium accumulation and cell death. Cell Mol Life Sci. 2024;82(1):32.","journal-title":"Cell Mol Life Sci"},{"issue":"7403","key":"2224_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"issue":"22","key":"2224_CR43","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","volume":"10","author":"MD Houslay","year":"2005","unstructured":"Houslay MD, Schafer P, Zhang KY. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today. 2005;10(22):1503\u201319.","journal-title":"Drug Discov Today"},{"issue":"3","key":"2224_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/bjp.2008.307","volume":"155","author":"D Spina","year":"2008","unstructured":"Spina D. Pde4 inhibitors: current status. Br J Pharmacol. 2008;155(3):308\u201315.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2224_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-16-1207","volume":"23","author":"K Kelly","year":"2017","unstructured":"Kelly K, Mejia A, Suhasini AN, et al. Safety and pharmacodynamics of the pde4 inhibitor roflumilast in advanced B-cell malignancies. Clin Cancer Res. 2017;23(5):1186\u201392.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2224_CR46","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998\u20131013.","journal-title":"Cancer Discov"},{"key":"2224_CR47","doi-asserted-by":"publisher","first-page":"21.9.1","DOI":"10.1002\/0471142727.mb2129s109","volume":"109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro JD, Wu B, Chang HY, et al. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol. 2015;109:21.9.1-.9.9.","journal-title":"Curr Protoc Mol Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02224-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:22:34Z","timestamp":1784802154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02224-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02224-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding note has been revised.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of The First Affiliated Hospital of Zhengzhou University.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were performed in compliance with the ARRIVE guidelines and the Basel Declaration. All animals received humane care according to the National Institutes of Health (USA) guidelines.","order":4,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}